Oral BVDU treatment of varicella and zoster in children with cancer
- PMID: 3987714
- DOI: 10.1007/BF00442138
Oral BVDU treatment of varicella and zoster in children with cancer
Abstract
In the period June 1980-April 1983, 21 children with malignant disease were admitted because of an intercurrent varicella or zoster infection. They were treated with the new antiviral drug BVDU [(E)-5-(2-bromovinyl)-2'-deoxyuridine]. The drug was administered orally at a dose of 15 mg/kg per day for 5 days. All our patients responded promptly to BVDU treatment and recovered completely from their varicella or zoster infections without complications. No toxic side-effects due to the drug were observed.
Similar articles
-
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.Eur J Cancer Clin Oncol. 1984 Apr;20(4):471-6. doi: 10.1016/0277-5379(84)90231-1. Eur J Cancer Clin Oncol. 1984. PMID: 6539202
-
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.Br Med J. 1980 Nov 1;281(6249):1178. doi: 10.1136/bmj.281.6249.1178. Br Med J. 1980. PMID: 7427624 Free PMC article. No abstract available.
-
[5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].Z Gesamte Inn Med. 1988 Dec 1;43(23):677-80. Z Gesamte Inn Med. 1988. PMID: 2854331 German.
-
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.Biochem Pharmacol. 2004 Dec 15;68(12):2301-15. doi: 10.1016/j.bcp.2004.07.039. Biochem Pharmacol. 2004. PMID: 15548377 Review.
-
Antiviral therapy of herpes simplex and varicella-zoster virus infections.Intervirology. 1997;40(5-6):343-56. doi: 10.1159/000150567. Intervirology. 1997. PMID: 9675639 Review.
Cited by
-
Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.Mol Ther. 2012 May;20(5):1002-13. doi: 10.1038/mt.2011.298. Epub 2012 Jan 24. Mol Ther. 2012. PMID: 22273576 Free PMC article.
-
Cardiovascular effects and safety of (non-aspirin) NSAIDs.Nat Rev Cardiol. 2020 Sep;17(9):574-584. doi: 10.1038/s41569-020-0366-z. Epub 2020 Apr 22. Nat Rev Cardiol. 2020. PMID: 32322101 Review.
-
Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus.Antimicrob Agents Chemother. 1985 Aug;28(2):246-51. doi: 10.1128/AAC.28.2.246. Antimicrob Agents Chemother. 1985. PMID: 3010841 Free PMC article.
-
Recognition and treatment of shingles.Drugs. 1994 Oct;48(4):528-48. doi: 10.2165/00003495-199448040-00004. Drugs. 1994. PMID: 7528128 Review.
-
Brivudine as a successful treatment for herpes zoster combined with chickenpox.Postepy Dermatol Alergol. 2025 Apr 15;42(3):322-324. doi: 10.5114/ada.2025.149542. eCollection 2025 Jun. Postepy Dermatol Alergol. 2025. PMID: 40672728 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous